Semax Peptide

Semax is a synthetic regulatory peptide developed for the experimental investigation of neurogenesis, neuroprotection, and cognitive mechanisms. Structurally derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), Semax is devoid of hormonal activity but functions as a potent modulator of neurotrophin expression—most notably Brain-Derived Neurotrophic Factor (BDNF)—making it a valuable tool in neurobiological and pathway-driven research.

In controlled laboratory settings, Semax is widely utilized to probe neuronal survival, neurotransmitter dynamics, and neuroendocrine regulatory networks, particularly those associated with central nervous system (CNS) plasticity and ischemic stress responses.

Key Features & Research Utility

• Synthetic neuroregulatory peptide for neuropharmacology and cognitive studies.

• High relevance to BDNF- and TrkB-mediated signaling pathways.

• Supports investigation of neuroplasticity, neuronal survival, and enkephalin degradation inhibition.

• Commonly applied in CNS, neuroprotection, hypoxia/ischemia, and memory research models.

• Suitable for both in vitro assays and in vivo preclinical studies.

Biochemical Profile

Mechanistic & Pathway Context

Semax primarily exerts its effects by modulating the expression and signaling of neurotrophins, leading to increased extracellular levels of BDNF and nerve growth factor (NGF), and the subsequent activation of TrkB receptor-dependent programs.

Semax-mediated cellular responses are frequently assessed through:

• BDNF and NGF expression profiling.

• TrkB receptor phosphorylation and downstream signaling cascades (e.g., PI3K/Akt and MAPK/ERK pathways).

• Neurotransmitter turnover assays (dopamine and serotonin dynamics).

• Enkephalinase inhibition and endogenous opioid peptide stabilization studies.

Because neurotrophic factors influence diverse neuronal populations, studies often incorporate specific receptor antagonists or induced hypoxic models to attribute survival and plasticity outcomes to specific biological pathways.

Research Applications

Preclinical Research Overview

Semax has been incorporated into a variety of preclinical experimental models, including rodent systems, to characterize neuroprotective signaling networks and downstream transcriptional responses following induced ischemic or hypoxic stress.

Models of cognitive deficit and neurotoxin exposure are frequently employed to validate the peptide’s pathway involvement in mitigating neuronal damage and promoting survival. Additional studies extend into neurochemical paradigms to examine the intersection between Semax signaling, dopaminergic pathways, and neuroinflammatory regulation.

Form & Analytical Verification

Semax is supplied as a synthetic research peptide suitable for controlled laboratory workflows. Standard quality-control procedures typically include:

• High-performance liquid chromatography (HPLC) for purity assessment.

• Mass spectrometry (MS) for identity confirmation.

• Batch documentation to support reproducibility in RUO study designs.

Disclaimer

• This product is sold For Research Use Only (RUO).

• Not for human or animal consumption.

• Not approved for diagnostic, therapeutic, medical, or veterinary use.

Important Legal & Educational Notice

This document is provided solely for general educational and informational purposes. It does NOT provide medical advice, legal advice, dosing guidance, treatment instructions, or recommendations of any kind. Nothing in this document recommends, suggests, instructs, or endorses the use of any peptide, compound, injection technique, dosage, timing, frequency, or anatomical site. All information must be independently verified with a licensed medical professional. This document is intended to comply with applicable laws and regulations of the State of California.